Science Aug 28 4 things to know about a new study on lithium and Alzheimer’s disease By Genesis Magpayo
Health Jul 30 Watch 6:34 Study reveals simple lifestyle changes could help prevent dementia An estimated 42% of Americans over 55 will eventually develop dementia. A new study revealed the strongest evidence yet that a balanced diet, consistent exercise and social activity helped improve cognition. Amna Nawaz discussed the study with Jessica Langbaum, the… By Amna Nawaz, Courtney Norris
Health Jul 28 Blood tests for Alzheimer’s may be coming to your doctor’s office. Here are 4 things to know New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported Sunday – but some appear to work far better than others. By Lauren Neergaard
Health Jul 02 FDA approves 2nd Alzheimer’s drug that can modestly slow dementia Kisunla is not a cure and slows worsening memory and cognitive problems by about seven months. By Matthew Perrone, Associated Press
Health Jun 10 FDA advisers back Alzheimer’s drug that can slow disease If the agency agrees with the panel's recommendation, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. shown to convincingly slow cognitive decline and memory problems due to Alzheimer's. By Matthew Perrone, Associated Press
May 06 New research shows people carrying 2 copies of a certain gene are more likely to have Alzheimer’s By Lauran Neergaard, Associated Press For the first time, researchers have identified a genetic form of late-in-life Alzheimer's disease. A gene called APOE4 has long been considered a key risk factor. But new research says if people inherit two copies of that gene it's not… Continue reading
Oct 26 Watch 5:32 Artist turns her work into love letters to husband fading into the fog of Alzheimer’s By Pamela Watts, Dorothy Dickie We bring you a story about art and love involving a Massachusetts artist whose work took a dramatic turn when her husband began to lose himself to Alzheimer’s disease. Rhode Island PBS Weekly reporter Pamela Watts reports for our arts… Continue watching
Aug 11 Insurers view new Alzheimer’s drug as experimental, won’t cover treatment for some customers By Tom Murphy, Associated Press Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients. Continue reading
Jul 06 Alzheimer’s drug Leqembi has full FDA approval, clearing way for Medicare coverage By Matthew Perrone, Associated Press The FDA gave it conditional approval in January based on early results suggesting the drug could modestly slow cognitive decline. Continue reading
May 23 Black people are more likely to develop Alzheimer’s than white people, CDC says By Kat Stafford, Associated Press About 14 percent of Black people in America over the age of 65 have Alzheimer’s, compared with 10 percent of white people, according to the Centers for Disease Control and Prevention. Continue reading